CompanyDrug

Huadong Medicine’s Biosimilar Victoza (Liraglutide) Accepted for NMPA Review

CompanyR&D

CorrectSequence Therapeutics’ tBE Tech Wins USPTO Patent for Gene Editing

CompanyDrug

Zai Lab’s Efgartigimod NDA Accepted by NMPA for Myasthenia Gravis

CompanyDeals

Overland ADCT BioPharma Doses First Patient in Zynlonta’s Phase III LOTIS-5 Study for DLBCL

CompanyDeals

Triastek Partners with Eli Lilly to Explore 3D Printing for GI Drug Delivery

CompanyDrug

Zhejiang Medicine’s ARX305 ADC Receives Clinical Trial Approval for CD70-Positive Cancers

CompanyDeals

GenScript ProBio Partners with ACT Therapeutics on CAR-T Cell Therapy Development

CompanyDrug

Abbisko Therapeutics’ ABSK021 Receives BTD for Giant Cell Tumor Treatment

Policy / Regulatory

NMPA Reclassifies Glucosamine Sulfate to OTC, Mandates Label Revisions

Policy / Regulatory

China’s JPO Launches VBP Round for Orthopedic Spine Consumables

CompanyDrug

HutchMed’s Orpathys-Tagrisso Combo Shows Promise in NSCLC at WCLC

CompanyDrug

Junshi Biosciences’ JS203 Bispecific Antibody Receives NMPA Green Light for NHL Study